Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans

[1]  Y. Xiang,et al.  Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters , 2022, Emerging microbes & infections.

[2]  Syed Faraz Ahmed,et al.  Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus , 2022, bioRxiv.

[3]  Todd G. Smith,et al.  Multiple lineages of Monkeypox virus detected in the United States, 2021- 2022 , 2022, bioRxiv.

[4]  N. Tikunova,et al.  An Update of Orthopoxvirus Molecular Evolution , 2022, Viruses.

[5]  S. Mallal,et al.  SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron , 2022, Cell.

[6]  F. Lienert,et al.  The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.

[7]  Bjoern Peters,et al.  SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19 , 2021, Cell Host & Microbe.

[8]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.

[9]  John T. Wilson,et al.  Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model , 2020, Scientific Reports.

[10]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[11]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[12]  Morten Nielsen,et al.  T Cell Epitope Predictions. , 2020, Annual review of immunology.

[13]  Sandeep Kumar Dhanda,et al.  T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species , 2020, Journal of Virology.

[14]  Morten Nielsen,et al.  IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..

[15]  Bjoern Peters,et al.  Characterization and epitope identification of the T cell response in non-allergic individuals exposed to mouse allergen , 2019, The World Allergy Organization journal.

[16]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[17]  Bjoern Peters,et al.  Development of a novel clustering tool for linear peptide sequences , 2018, Immunology.

[18]  G. Sutter,et al.  Chapter Five Modified Vaccinia Virus Ankara History, Value in Basic Research, and Current Perspectives for Vaccine Development , 2017, Advances in Virus Research.

[19]  S. Mallal,et al.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.

[20]  Bjoern Peters,et al.  Automatic Generation of Validated Specific Epitope Sets , 2015, Journal of immunology research.

[21]  John Sidney,et al.  Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes , 2014, BCB.

[22]  K. Früh,et al.  T Cell Inactivation by Poxviral B22 Family Proteins Increases Viral Virulence , 2014, PLoS pathogens.

[23]  Bjoern Peters,et al.  Evaluating the Immunogenicity of Protein Drugs by Applying In Vitro MHC Binding Data and the Immune Epitope Database and Analysis Resource , 2013, Clinical & developmental immunology.

[24]  J. Sidney,et al.  Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques , 2013, Virology.

[25]  J. Greenbaum,et al.  Dissecting Mechanisms of Immunodominance to the Common Tuberculosis Antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ) , 2012, The Journal of Immunology.

[26]  Yun Zhang,et al.  ViPR: an open bioinformatics database and analysis resource for virology research , 2011, Nucleic Acids Res..

[27]  B. Moss.  Smallpox vaccines: targets of protective immunity , 2011, Immunological reviews.

[28]  G. Pauli,et al.  Orthopox Viruses: Infections in Humans , 2010, Transfusion Medicine and Hemotherapy.

[29]  Ravi V. Kolla,et al.  Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. , 2009, Vaccine.

[30]  Carole R Baskin,et al.  Vaccinia virus vaccines: past, present and future. , 2009, Antiviral research.

[31]  R. Osman,et al.  Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide Dynamism , 2009, The Journal of Biological Chemistry.

[32]  R. Jacobson,et al.  The immunology of smallpox vaccines , 2009, Current opinion in immunology.

[33]  A. Rothman,et al.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. , 2008, Human immunology.

[34]  C. Pinilla,et al.  Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation , 2008, Proceedings of the National Academy of Sciences.

[35]  Magdalini Moutaftsi,et al.  Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve1 , 2008, The Journal of Immunology.

[36]  D. Molina,et al.  An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling , 2008, Journal of Virology.

[37]  P. Earl,et al.  Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax , 2007, Journal of Virology.

[38]  R. Ahmed,et al.  Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection , 2007, Clinical and Vaccine Immunology.

[39]  D. Koelle,et al.  Diversity in the acute CD8 T cell response to vaccinia virus in humans , 2007, The Journal of Immunology.

[40]  P. Earl,et al.  DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge , 2007, Virology.

[41]  Magdalini Moutaftsi,et al.  Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses1 , 2007, The Journal of Immunology.

[42]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[43]  S. Crotty,et al.  Immunity and immunological memory following smallpox vaccination , 2006, Immunological reviews.

[44]  James F. Jones,et al.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. , 2006, Immunity.

[45]  Bjoern Peters,et al.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Jon M Hanifin,et al.  Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox , 2005, Nature Medicine.

[47]  K. Reimann,et al.  Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus , 2005, Nature Medicine.

[48]  J. Stone,et al.  HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Venzon,et al.  Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. , 2005, The Journal of infectious diseases.

[50]  P. Earl,et al.  Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox , 2004, Nature.

[51]  G. McFadden,et al.  Poxviruses and immune evasion. , 2003, Annual review of immunology.

[52]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[53]  John Cruz,et al.  Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201–restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses , 2003, The Journal of experimental medicine.

[54]  Hans-Georg Rammensee,et al.  Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Derek Middleton,et al.  A new allele frequency database , 2002 .

[56]  F. Falkner,et al.  The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. , 1998, Virology.

[57]  B. Moss,et al.  Poxviruses as expression vectors. , 1997, Current opinion in biotechnology.

[58]  T. S. Jones,et al.  Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. , 1987, The New England journal of medicine.

[59]  Z Jezek,et al.  Human monkeypox: a study of 2,510 contacts of 214 patients. , 1986, The Journal of infectious diseases.